Current Treatment Options in Oncology

Papers
(The TQCC of Current Treatment Options in Oncology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Role of Metastasis-Directed Therapy in Genitourinary Cancers110
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead77
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer75
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia74
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes61
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma55
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer55
An Update on Temporal Bone Paragangliomas54
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies53
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)45
The Role of Nursing in the Delivery of Cardio-Oncology44
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect44
HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?39
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?39
Chronic Lymphocytic Leukemia: Chemotherapy Free and Other Novel Therapies Including CAR T37
Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer36
Options and Considerations in the Management of Peritoneal Disease in Patients with Small Bowel Neuroendocrine Tumors34
Management of Fatigue in Patients with Advanced Cancer34
Recent Advances in Liver Transplantation for Hepatocellular Carcinoma33
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers30
Small Cell Lung Cancer—An Update on Chemotherapy Resistance30
Approach to Localized Squamous Cell Cancer of the Esophagus29
Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?29
Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities28
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer28
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements28
Advances in Targeted Therapy for Metastatic Prostate Cancer26
Regorafenib for the Treatment of Sarcoma26
Reshaping Treatment Paradigms for Advanced Renal Cell Cancer Patients and Improving Patient Management26
Revolutionizing Breast Cancer Therapeutics: Intersecting Frontiers of Precision Medicine, Nanotechnology, and Drug Delivery Innovations25
The Review of Modified Intersphincteric Resection in the Treatment of Ultra-Low Rectal Cancer25
Steroid Premedication and Monoclonal Antibody Therapy: Should We Reconsider?24
Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia23
New Treatment Options for Newly-Diagnosed and Relapsed Chronic Lymphocytic Leukemia23
Novel Approaches for the Treatment of Patients with Richter’s Syndrome22
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs22
Gastric Cancer with Sarcopenia: an Area Worth Focusing On22
Optimal Strategies for Colorectal Cancer Screening21
R0 Resection in Recurrent Gynecologic Malignancy: Pelvic Exenteration and Beyond21
Recognition and Management of the Long-term Effects of Cranial Radiation21
A Comprehensive Review on the Role of Lurbinectedin in Soft Tissue Sarcomas21
Response Evaluation of Neoadjuvant Therapies in Sarcoma21
Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?21
Correction to: The Microbiome: the Link to Colorectal Cancer and Research Opportunities21
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors20
Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy20
Contemporary Review of Adenocarcinoma of the Cervix20
Treatment Options for Brain Metastases20
New Therapeutic Targets in RAS Wild-type Pancreatic Cancer19
Review of Bone Metastasis in Gynecologic Malignancies: Evaluation and Treatment19
Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer19
Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis19
Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities18
Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer18
Therapeutic Challenges in the Management of Serous Endometrial Intraepithelial Carcinoma (SEIC)18
Dyadic Interventions for LGBTQ+ Individuals Facing Cancer: A Narrative Review18
New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms18
Novel Estrogen Receptor-Targeted Agents for Breast Cancer18
Neoadjuvant Photodynamic Therapy: An Updated Therapeutic Approach for Non-Melanoma Skin Cancers17
One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract17
Treating Chronic Pain with Buprenorphine—The Practical Guide17
Navigating PARP Inhibitor Resistance in Ovarian Cancer: Bridging Mechanistic Insights To Clinical Translation17
Promising Blood-Based Biomarkers for Melanoma: Recent Progress of Liquid Biopsy and Its Future Perspectives17
Progress in the Treatment of Small Intestine Cancer17
Research Progress on Ferroptosis in Multiple Myeloma17
Updates in Management of Malignant Pleural Mesothelioma16
How Genetics Can Drive Initial Therapy Choices for Older Patients with Acute Myeloid Leukemia16
Perioperative Immune Checkpoint Inhibitors for the Treatment of Locally Advanced Gastric and Gastroesophageal Junction Cancer: Current Status and Future Prospects16
What are the Optimal Systemic Treatment Options for Rhabdomyosarcoma?16
New Developments in Systemic Management for High-Risk Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer16
The Dilemma of Treating Delirium: the Conundrum of Drug Management16
Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma16
Treatment of Non-Small Cell Lung Cancer with Atypical EGFR Mutations15
Updates in Breast Cancer Screening and Diagnosis15
Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and Immunotherapy15
Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives15
Advancing Bladder Cancer Management: The Role of Neoadjuvant and Adjuvant Therapies and Biomarkers in Muscle Invasive Bladder Cancer15
A Review on Integrating Breast Cancer Clinical Data: A Unified Platform Perspective15
New Insights into the Understanding of Mechanisms of Radiation-Induced Heart Disease15
Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus14
The Role of Induction Therapy for Sinonasal Cancers14
New Developments in Treating RAS-Mutated Metastatic Colorectal Cancer14
Correction to: Cardiotoxicity of Systemic Melanoma Treatments14
Taxane-Associated Acute Pain Syndrome: a Review of its Features and Management13
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management13
Targeting the Renin–angiotensin–aldosterone System (RAAS) for Cardiovascular Protection and Enhanced Oncological Outcomes: Review13
Advances in PSMA-Targeted Radionuclide Therapeutics13
Re-thinking the Role of Thoracic Radiotherapy in the First-Line Treatment for Extensive-Stage Small Cell Lung Cancer13
HER2-Positive Metastatic Colorectal Cancer12
Advancements in Melanoma Therapies: From Surgery to Immunotherapy12
ctDNA to Guide Treatment of Colorectal Cancer: Ready for Standard of Care?12
“When Less is More”: Paradigm Shifts in Radiation Treatment for Early-Stage Breast Cancer12
Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance12
Extent of Resection and Outcomes of Patients with Primary Malignant Brain Tumors12
Therapeutic Management of Malignant Wounds: An Update12
Myxoid Liposarcomas: Systemic Treatment Options12
Hypnosis for Symptom Management in Adult Cancer Patients: What is the Evidence?12
Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?12
RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming12
Correction to: Recent Advances in Succinate Dehydrogenase Deficient Gastrointestinal Stromal Tumor Systemic Therapies12
The Role of SIRT1 in Leukemia12
Complex Persistent Opioid Dependence—an Opioid-induced Chronic Pain Syndrome12
Management of Functional Pancreatic Neuroendocrine Neoplasms11
The Use of Targeted Agents in the Treatment of Gynecologic Cancers11
Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer11
Neuroendocrine Tumors: Germline Genetics and Hereditary Syndromes11
Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer11
Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches11
Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation11
Osteogenic Sarcoma of the Head and Neck: Is Chemotherapy Needed?11
Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic11
Dermatofibrosarcoma Protuberans (DFSP): Diagnostics and Molecular Pathology11
The Role of Pharmacogenomics in Opioid Prescribing11
Emerging Therapeutic Approaches to Pancreatic Adenocarcinoma: Advances and Future Directions11
The Improving Outcomes in Relapsed-Refractory Diffuse Large B Cell Lymphoma: The Role of CAR T-Cell Therapy11
Integrating Systemic Therapies into the Multimodality Therapy of Patients with Craniopharyngioma11
0.53118515014648